NICOLE STALLINGS: Open Payments
NPI 1538416748 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,916 in 112 payments from 21 companies in 2025. Trend: 2023 $343 · 2024 $639 · 2025 $2,916
Food & beverage: $2,737Education: $179
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 25 | $703 |
| Janssen Biotech, Inc. | 11 | $483 |
| ABBVIE INC. | 19 | $349 |
| Amgen Inc. | 15 | $252 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $161 |
| GlaxoSmithKline, LLC. | 7 | $142 |
| AstraZeneca Pharmaceuticals LP | 6 | $134 |
| KYOWA KIRIN, INC. | 1 | $127 |
| PFIZER INC. | 6 | $119 |
| Radius Health, Inc. | 3 | $77 |
Products named: Bimzelx, TREMFYA, RINVOQ, BENLYSTA, SAPHNELO, CRYSVITA, XELJANZ, KRYSTEXXA.
Industry payments across GA — which companies pay providers there.
